Kewaunee Scientific (NASDAQ:KEQU) Issues Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) released its quarterly earnings results on Wednesday. The technology company reported $0.91 earnings per share for the quarter, FiscalAI reports. The firm had revenue of $70.10 million for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.

Kewaunee Scientific Trading Up 3.7%

KEQU traded up $1.43 on Wednesday, hitting $40.21. 4,943 shares of the company were exchanged, compared to its average volume of 16,010. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32. The firm has a fifty day simple moving average of $41.39 and a two-hundred day simple moving average of $47.04. The stock has a market capitalization of $115.40 million, a PE ratio of 9.74 and a beta of 0.61. Kewaunee Scientific has a 12 month low of $30.33 and a 12 month high of $71.33.

Insider Transactions at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 6,880 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $43.20, for a total transaction of $297,216.00. Following the completion of the transaction, the vice president directly owned 8,248 shares of the company’s stock, valued at approximately $356,313.60. This represents a 45.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Donald T. Gardner III sold 3,000 shares of the stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $42.76, for a total transaction of $128,280.00. Following the sale, the chief financial officer owned 11,564 shares of the company’s stock, valued at approximately $494,476.64. This represents a 20.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 15,880 shares of company stock worth $689,471. Insiders own 13.30% of the company’s stock.

Institutional Trading of Kewaunee Scientific

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Goldman Sachs Group Inc. lifted its stake in shares of Kewaunee Scientific by 125.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after purchasing an additional 10,803 shares during the period. Punch & Associates Investment Management Inc. bought a new position in Kewaunee Scientific in the first quarter worth $788,000. OMERS ADMINISTRATION Corp purchased a new position in Kewaunee Scientific during the first quarter valued at $284,000. American Century Companies Inc. boosted its holdings in shares of Kewaunee Scientific by 43.4% during the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after buying an additional 14,889 shares in the last quarter. Finally, Minerva Advisors LLC grew its position in shares of Kewaunee Scientific by 5.0% in the 2nd quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company’s stock worth $4,501,000 after buying an additional 3,677 shares during the period. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “hold (c+)” rating on shares of Kewaunee Scientific in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific currently has an average rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.